This compound is a pharmaceutical intermediate featuring a thiophene core with bromomethyl, nitrophenyl, and difluorophenyl substituents. It is characterized by high lipophilicity and multiple halogen and ester functional groups.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 308831-95-0
Ethyl 2-[[(2,6-difluorophenyl)methyl](ethoxycarbonyl)amino]-4-methyl-5-(4-nitrophenyl)-3-thiophenecarboxylate
pharmaceutical intermediate
Dutasteride EP impurity D
Pharmaceutical impurity reference standard
L-Cystine dihydrochloride
Pharmaceutical intermediate for cysteine derivatives
6-Chloromethyl-2-methylpyridinium chloride
pharmaceutical intermediate
(3R)-3-Aminopiperidine, 3-BOC protected
Pharmaceutical intermediate for API synthesis
Ethyl 2-{[(2,6-difluorophenyl)methyl](ethoxycarbonyl)amino}-4-[(dimethylamino)methyl]-5-(4-nitrophenyl)thiophene-3-carboxylate
pharmaceutical intermediate
3-Thiophenecarboxylic acid, 2-[[(2,6-difluorophenyl)methyl](propoxycarbonyl)amino]-4-[(dimethylamino)methyl]-5-(4-nitrophenyl)-, ethyl ester
research compound
Ethyl 2-((2,6-difluorobenzyl)(methoxycarbonyl)amino)-4-((dimethylamino)methyl)-5-(4-nitrophenyl)thiophene-3-carboxylate
Pharmaceutical intermediate
ethyl 4-(bromomethyl)-2-[(2,6-difluorophenyl)methyl-ethoxycarbonylamino]-5-(4-nitrophenyl)thiophene-3-carboxylate
BZMCAJIMPLBMOU-UHFFFAOYSA-N
CCOC(=O)C1=C(SC(=C1CBr)C2=CC=C(C=C2)[N+](=O)[O-])N(CC3=C(C=CC=C3F)F)C(=O)OCC